Status:
ACTIVE_NOT_RECRUITING
Effort During Resistance Training in Type 2 Diabetes
Lead Sponsor:
University of New Mexico
Conditions:
Type2 Diabetes Mellitus
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
In this study the primary aims are to investigate the effect of resistance exercise training with different degrees of effort on glycemic control and psychological variables in individuals living with...
Detailed Description
Resistance exercise training can be both effective for the management of type 2 diabetes mellitus (T2DM) and appealing for individuals living with T2DM, and has been shown to be a viable exercise pres...
Eligibility Criteria
Inclusion
- Living with type 2 diabetes mellitus
Exclusion
- Have a significant cognitive impairment,
- Are non-ambulatory,
- Have lower extremity amputation,
- Have renal failure,
- Have liver disease,
- Have uncontrolled hypertension (\>160 mmHg systolic and/or \>100 mmHg diastolic),
- Have unstable cardiovascular disease,
- Have a history of severe cardiovascular problems,
- Have decompensated heart failure,
- Have uncontrolled arrhythmias,
- Have severe pulmonary hypertension (mean pulmonary arterial pressure \>55 mm Hg),
- Have severe and symptomatic aortic stenosis,
- Have acute myocarditis, endocarditis, or pericarditis,
- Have aortic dissection,
- Have Marfan syndrome,
- Have unrepaired aortic aneurysm,
- Have proliferative diabetic retinopathy,
- Have rapidly progressive terminal illness,
- Are unable to perform resistance exercise to due preexisting musculoskeletal conditions (e.g., joint pain, chronic injury or tendinopathy),
- Are under biguanide (metformin) treatment, but are taking for less than 3 months,
- Have taken drugs known to increase the risk of tendon disorders (e.g., tendinopathy and tendon rupture) within the last 6 months. These drugs include, but may not be limited to: fluoroquinolones, glucocorticoids, aromatase inhibitors, anabolic steroids, antiretrovirals, isotretinoin, cephalexin, rituximab, sitagliptin, cephalosporins, azithromycin, and sulfonamides.
- Are pregnant or trying to become pregnant during the study,
- Are prisoners,
- Are persons that require a legally authorized representative.
- Temporary exclusions include:
- Being subjected to recent surgeries for which resistance training is not recommended,
- Have symptomatic hernias,
- Have acute illness,
- Have recent fractures, or other injuries until resolved.
Key Trial Info
Start Date :
September 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06497842
Start Date
September 10 2024
End Date
February 1 2026
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNM Exercise Physiology Lab
Albuquerque, New Mexico, United States, 87131-0001